Skip to main content
Download PDF

Salivary cotinine concentrations in daily smokers in Barcelona, Spain: a cross-sectional study

BMC Public Health volume 9, Article number: 320 (2009) Cite this article

Abstract

Background

Characterizing and comparing the determinant of cotinine concentrations in different populations should facilitate a better understanding of smoking patterns and addiction. This study describes and characterizes determinants of salivary cotinine concentration in a sample of Spanish adult daily smoker men and women.

Methods

A cross-sectional study was carried out between March 2004 and December 2005 in a representative sample of 1245 people from the general population of Barcelona, Spain. A standard questionnaire was used to gather information on active tobacco smoking and passive exposure, and a saliva specimen was obtained to determine salivary cotinine concentration. Two hundred and eleven adult smokers (>16 years old) with complete data were included in the analysis. Determinants of cotinine concentrations were assessed using linear regression models.

Results

Salivary cotinine concentration was associated with the reported number of cigarettes smoked in the previous 24 hours (R 2 = 0.339; p < 0.05). The inclusion of a quadratic component for number of cigarettes smoked in the regression analyses resulted in an improvement of the fit (R 2 = 0.386; p < 0.05). Cotinine concentration differed significantly by sex, with men having higher levels.

Conclusion

This study shows that salivary cotinine concentration is significantly associated with the number of cigarettes smoked and sex, but not with other smoking-related variables.

Peer Review reports

Background

Nicotine, the main alkaloid of tobacco, is responsible for its addictive effect. It is readily absorbed from tobacco smoke, and its concentration rises over 6-8 hours during the day in regular smokers [1]. About 70 to 80% of nicotine is metabolized to cotinine [2]. As the primary metabolite of nicotine, cotinine has been widely used as a specific biomarker of tobacco exposure because its half-life in the body (12-20 hours) is longer than that of nicotine (3-4 hours) [1, 2]. Cotinine in biological materials is suitable for assessment of doses over short periods of time (from 1 to 10 days, in urine, plasma, or saliva) or longer periods (weeks or months, in hair or nails). Consequently cotinine concentration is feasibly used as a biomarker in epidemiological studies [3–5].

Cotinine measurements have been used to describe and compare patterns of tobacco consumption in smokers in different countries to establish if addiction and smoking patterns vary across populations [6–8]. These studies show that the number of cigarettes smoked is the main determinant of salivary cotinine concentrations [9]. These studies have been conducted in selected samples from a variety of countries at different stages of the tobacco epidemic, such as China, Mexico, Brazil, and Poland [9, 10]. However, there is scant information about the relation between cotinine measurements and smoking patterns in samples from the general population.

Spain is currently in an advanced stage of the tobacco epidemic [10, 11]. Data from the 2006 Spanish National Health Interview Survey show prevalence rates of daily smokers of 31.6% and 21.5% in adult men and women, respectively [12]. In men, a steady increase in smoking occurred during the first half of the twentieth century, reaching a peak prevalence rate of 59.1% in the nineteen-seventies. This peak was followed by a decade of stabilization and a continued decrease of smoking until the present. Uptake of smoking in women was delayed, with a prevalence rate of 5% through the nineteen-seventies. This was followed by a substantial increase throughout the next two decades (22.5% by 1995), which only recently stopped [11, 13, 14].

An understanding of cotinine concentration and smoking patterns at the population level is potentially useful to design suitable strategies for cessation. The aim of this study is to describe and characterize the distribution of salivary cotinine concentration in a representative sample of adult (>16 years old) daily smokers in Barcelona, Spain.

Methods

Study design and subjects

We conducted a cross-sectional study among the general population of Barcelona, Spain, between March 2004 and December 2005. A representative random sample by age, sex, and district was drawn from the official 2001 population census of Barcelona, a reliable source of population-based information. To detect a difference in cotinine concentration in smokers of 50 ng/ml (with a mean value of 500 ng/ml and a standard deviation of 200 ng/ml), with an alpha of 5% and a beta of 10% (statistical power of 90%), we estimated that a sample size of 337 smokers would be needed. Considering a 27% prevalence of smoking from the 2001 Health Survey of Barcelona, we estimated a needed sample size of 1560 people, taking into account smokers and non-smokers. In cases of non-response, substitution by persons of the same sex within the 5-year age group and residing in the same district was allowed according to protocol.

Smoking status, secondhand smoke exposure as well as demographic information were obtained by questionnaire, and a saliva specimen was collected to determine cotinine concentration. The research and ethics committee of the Bellvitge University Hospital approved the study protocol, and informed consent was obtained from all participants. The procedure was as follows: a personal letter was sent to eligible participants, and trained interviewers contacted the subjects (or a proxy for children) at home and informed them about the study. Participants signed the consent form, answered a questionnaire, and provided a saliva specimen at home. The study ended in December 2005 with a new Spanish law banning smoking in public places and enclosed workplaces coming into effect in January 2006 [15]. We expected changes in smoking behavior after this date (number of cigarettes smoked by smokers and passive exposure levels in nonsmokers) and hence 315 selected participants were not approached. By the end of the study, 1245 subjects had been interviewed (participation rate of 79.8% from the initial sample drawn). The study design allowed replacement of the index person by another person of the same sex, 5-year age group, and district of residence. In 49.3% of cases the first selected index person was interviewed; 24.4% of first substitutes were interviewed; and 26.3% of second or subsequent substitutes were interviewed. The final sample interviewed included 285 daily smokers (at least 1 cigarette per day), 62 occasional (non-daily) smokers, 354 ex-smokers, 525 never-smokers, and 19 people were less than 17 years of age. The present report is based on adults who were daily smokers.

Measures

Questionnaire

We obtained information on demographics, and levels of secondhand smoke exposure at home, work or study centre, and during leisure time. Detailed information was also collected on self-reported smoking for smokers: number of cigarettes smoked daily, number of cigarettes smoked during the previous 24 and 48 hours, duration of smoking, brand of cigarettes smoked most often, brands of cigarettes smoked during the survey day and in the previous day, use of cigarettes with filter tips, depth and frequency of inhalation, use of other tobacco products, and use of nicotine gum or patches.

Body mass index

We measured participants' weights and heights using a standardized protocol (with an electronic portable scale and a tape measure). Body mass index (BMI) was computed as weight/squared height (kg/m2) and stratified using standard categories of BMI (underweight: <18.50, normal: 18.50-24.99, overweight: 25.00-29.99, and obese: ≥30.00 kg/m2).

Saliva specimen

A standardized protocol for saliva collection was used. Participants were asked to rinse their mouths and then suck a lemon-flavored candy (Smint®) to stimulate saliva production. They were asked first to spit out a small amount of saliva, and then to spit about 8 ml into a polypropylene test tube. The specimens were kept at 4°C and then frozen at -20°C in 3 ml aliquots for transport in dry ice to the Bioanalysis Research Group of the Municipal Institute for Medical Research (IMIM-Hospital del Mar). Cotinine concentration in nanograms per milliliter (ng/ml) was determined by gas chromatography, with detection by mass spectrometry (GC/MS) [16, 17]. With this technique, cotinine concentration can be quantified as low as 1 ng/ml (limit of detection: 0.3 ng/ml; quantification error <15%).

Data analyses

Sample exclusions

Of the 285 current adult daily smokers, 7 were excluded from the analysis either because they did not provide a saliva specimen or that cotinine determination was not possible (i.e., insufficient sample). We included only cigarette smokers, hence 53 people who smoked other tobacco products (mainly cigars and roll tobacco) were excluded, as were 2 subjects who used nicotine gum or nicotine patch for cessation. Additionally, 12 people were excluded because their cotinine concentrations were too high in relation to the self-reported consumption, that is, over 35 ng/ml per one cigarette smoked. This level of cotinine represents the maximum level of absorption per one cigarette smoked, assuming that the typical cotinine concentration of 12 ng/ml per cigarette is equivalent to the usual absorption of 1 mg of nicotine per cigarette, and that a cigarette smoker can absorb up to 3 mg of nicotine per cigarette with very intense smoking [9]. The final sample for analysis consisted of 211 current daily smokers.

Variables

The outcome variable was salivary cotinine concentration (ng/ml). Potential modifiers of the relation between cotinine concentration and the number of cigarettes smoked in the last 24 hours included individual characteristics (sex, age, educational level, BMI), type of tobacco (use of regular or non-regular cigarettes [light, ultralight, mentholated, low nicotine yield], use of blond or black tobacco, and use of filter tips), and smoking behavior (frequency and depth of smoke inhalation).

Statistical analyses

Medians and 25th and 75th percentiles (interquartile range, IQR) of salivary cotinine concentration were computed according to the different strata of the potential modifiers. Median cotinine concentrations across the different variables were compared using non-parametric test for medians. Simple linear regression was used to derive the average increase in cotinine level (ng/ml) per one cigarette smoked, adjusting for the remaining variables. We analyzed the relation between number of cigarettes smoked in the previous 24 hours and salivary cotinine concentration using multiple linear regressions according to the strata of the potential modifiers of interest. Since the distributions of cotinine concentration and of the number of cigarettes were skewed, we first used log transformation, but the fit of the models did not improve. Following previous studies [9, 18], we included a quadratic term for number of cigarettes to improve the models' fit. We assessed the improvement of fit between the adjusted and simple model with the F test statistic [19]. All models were tested for the applicability of conditions of linear regression (model specification, normality of errors, homoscedasticity, absence of multicollinearity, absence of outliers and lack of self-correlation). All analyses were performed using SPSS v13.0 (SPSS Inc., Chicago, IL).

Results

Among the 211 current daily smokers (104 men and 107 women), the median age was 42.0 years (IQR 31.0-53.0). The sample was uniformly distributed across educational levels. The majority of participants (56%) were of normal weight and 19.4% had smoked more than 20 cigarettes in the last 24 hours. The median number of cigarettes smoked according to selected sociodemographic and smoking characteristics is shown in Table 1. The median number of cigarettes smoked in the last 24 hours was 15.0 (IQR 8.0-20.0), with significantly higher consumption in men compared to women (p < 0.05). Differences in cigarette consumption were also found by type of tobacco: smokers of black tobacco had smoked more cigarettes in the last 24 hours (median: 20 cigarettes) than smokers of blond tobacco (median: 12 cigarettes, p < 0.05).

Table 1 Median number of cigarettes smoked in the last 24 hours and interquartile ranges in adult daily smokers, according to individual characteristics, type of tobacco, and smoking characteristics.
Full size table

Median cotinine concentrations by individual characteristics and smoking parameters are shown in Table 2. The overall median cotinine concentration was 146.5 ng/ml (IQR 86.8-220.5). Median cotinine concentration differed significantly by sex (172.6 ng/ml for men and 120.7 ng/ml for women, p < 0.001) regardless of the number of cigarettes smoked. Significant differences in cotinine concentrations were not found by age, educational level, or BMI (Table 2).

Table 2 Median cotinine concentrations (ng/ml) and interquartile ranges in adult daily smokers, according to individual characteristics, type of tobacco, and smoking characteristics.
Full size table

As shown in Table 2, we found no statistically significant differences in the salivary cotinine concentration by type of cigarettes, use of filter, frequency, or depth of inhalation. Median cotinine concentration was higher among smokers of black tobacco (180.2 ng/ml) than among smokers of blond tobacco (137.0 ng/ml; p = 0.043). This association was confounded by the higher median consumption by smokers of black tobacco (Table 1), and by the predominance of men (70%) among users of black tobacco. There was no association between the type of tobacco smoked and cotinine concentration within strata of number of cigarettes smoked (1-9, 10-19, and = 20 cigarettes in the last 24 hours) or of sex (data not shown).

Coefficients (β) derived from simple linear regression estimate the average increase in cotinine concentration per one cigarette smoked during the previous 24 hours (Table 3). The increase in cotinine concentration per one cigarette smoked was 5.3 ng/ml in men and 7.7 ng/ml in women. No consistent trend was found in cotinine concentration by age; the greatest increase was observed in participants <45 years (β = 7.0; 95% CI, 5.2 - 8.8 ng/ml). Cotinine level increase per one cigarette smoked was greater among subjects who were at normal weight (8.2 ng/ml) and overweight (6.5 ng/ml) than in those who were obese (1.9 ng/ml). By type of tobacco, the greatest increase in cotinine concentration per one cigarette smoked was found in those smoking non-regular cigarettes (8.4 ng/ml) and in smokers of blond tobacco (6.9 ng/ml). Consistent trends were not found by use of filter tip, frequency, or depth of inhalation.

Table 3 Average increase in cotinine concentration (ng/ml) in adult daily smokers per one cigarette smoked in the previous 24 hours, according to individual characteristics, type of tobacco, and smoking characteristics. Barcelona (Spain), 2004-2005.
Full size table

The distribution of salivary cotinine concentration in relation to the number of cigarettes smoked during the 24 hours prior to saliva collection is shown in Fig 1. In the simple unadjusted linear model the number of cigarettes smoked in the last 24 hours was a predictor of cotinine concentrations (R 2 = 0.339; solid line). A significant improvement of the fit was obtained with a quadratic model, in which the number of cigarettes smoked accounted for almost 39% (adjusted R 2) of the variance, and the exposure-response relationship leveled-off near 20 cigarettes (Fig. 1; dashed line). [see Additional file 1]

Figure 1
figure1

The distribution of salivary cotinine concentration in relation to the number of cigarettes smoked during the 24 hours prior to saliva collection.

Full size image

Due to differences found in cotinine concentrations between men and women, we analyzed these groups separately (Table 4). We observed an increment of 15.7 and 11.2 ng/ml in cotinine concentration per one cigarette smoked at a consumption of 1 cigarette per day in the quadratic model for men and for women, respectively. Further adjustment for age, educational level, and BMI in the quadratic model showed the best fit of the data with a similar increase in the cotinine concentration by cigarettes smoked (Table 4). Adjustment for other potential confounders identified in the bivariate analysis did not improve the model fit and hence these variables were not included in the final models (data not shown). Fig 2 shows the regression lines from linear and quadratic models for men and women. We verified the final models for error specification, normality, homoscedasticity, multicollinearity, outliers and self-correlation, and all diagnostics showed that the chosen models fulfilled the assumption [see Additional file 1]

Figure 2
figure2

The regression lines from linear and quadratic models for men and women.

Full size image
Table 4 Average increase in cotinine concentration (ng/ml) in adult daily smokers per one cigarette smoked in the previous 24 hours by type of regression model.
Full size table

Discussion

This is the first study on smoking behavior in a Spanish adult population using both a questionnaire and a biomarker of tobacco exposure. Salivary cotinine concentration was associated with the number of cigarettes smoked in the last 24 hours. This relation was better explained with a quadratic function and in separate strata for men and women. The greater the number of cigarettes smoked, the greater the cotinine concentration in a linear scale up to 20 cigarettes per day, after which the association plateaus. A similar relation between salivary [6–9, 20] or serum [21] cotinine concentrations and number of cigarettes smoked has been observed in other studies. Abrams et al. dichotomized tobacco consumption, and found that for smokers of less than 25 cigarettes per day, salivary cotinine concentration was highly correlated with tobacco consumption, while among heavier smokers the relation was not evident [22].

Other studies have found that cotinine concentration plateaus at different numbers of cigarettes: 25 cigarettes per day [23], 5 cigarettes per day [24], and 4 cigarettes per day in adolescent smokers [25]. The evidence suggests that cotinine concentration rises in a non-linear fashion with increasing number of cigarettes smoked, but the point where concentrations level off may vary across different populations. This finding suggests a difference in how people regulate their intake of nicotine to reach the desired dose [2], even for adolescents, who may be more susceptible to nicotine than adults and require only 4-5 cigarettes per day to satisfy their nicotine cravings [25].

We observed that cotinine concentrations differed by sex, regardless of the number of cigarettes smoked. Some studies reported similar findings of higher cotinine concentrations in men than in women [7, 23, 26, 27], but other studies did not find differences by sex [6, 28]. Association between urinary cotinine and cigarettes smoked according to sex was found in a study in the USA: urinary cotinine concentrations in men increased up to 34 cigarettes per day and then declined, while no flattening was observed in women [29]. The differences we observed by sex could reflect not only differences in tobacco consumption by sex, i.e., men usually smoke more cigarettes than women, but also a difference in the metabolism of nicotine between men and women [30, 31].

Our data showed a higher cotinine concentration in smokers of black tobacco that did not persist with control for the number of cigarettes smoked. Whereas uptake of carcinogens is higher among black tobacco smokers [32–34], differences in nicotine uptake by type of tobacco smoked have not been reported [35]. In our study, use of filter, frequency, and depth of inhalation were not related to cotinine concentrations. An explanation of these results could be that smokers tend to maintain the same intake level of nicotine by drawing in more smoke per cigarette when they try to smoke fewer cigarettes. Benowitz et al. reported that among people who reduced from 37 to 5 cigarettes per day on average, the intake of tobacco toxins per cigarette increased roughly threefold [36]. This could also explain how cotinine concentrations level-off in smokers of more than 20 cigarettes per day, when a certain intake of nicotine is achieved [8, 9].

The role of age in cotinine concentrations is still not clear, since our results, as well as previous studies [7, 37], indicated no association between cotinine concentrations and age, while others have found a significant association [6, 18, 29, 38]. Some studies have modeled the relation between cotinine concentrations and cigarette consumption by taking into account several of these variables. The fit of the multivariate model improved once age, BMI, educational level, and a quadratic term for cotinine were included.

Study limitations and strengths

To our knowledge, this is one of the few studies in which information about tobacco exposure was obtained in a representative random sample of the general population with a simultaneous use of a questionnaire and a biological marker. In the USA, the National Health and Nutrition Examination Survey (NHANES) provides population-based national estimates of smoking prevalence using both standard questionnaire and serum cotinine concentration [39]. Most previous studies were based on selective samples from existing observational studies [6, 8, 18, 25, 37] or smoking cessation trials [21, 22, 29]. Other factors affecting validity also need to be considered. Although the use of self-reported data from questionnaires could be a source of bias, self-reports on smoking are accurate and have acceptable validity [40, 41]. Cotinine is a specific biomarker of tobacco exposure [1, 2], and the laboratory methods are highly sensitive [17].

Some potential limitations deserve consideration. We found that the model fit could be affected by the measurement scale of the number of cigarettes. Smokers tend to round up the number of cigarettes smoked, particularly heavy smokers [42], and hence some information bias due to digit preference cannot be disregarded. While some loss of representativeness due to non-response might also be possible, the sample did not differ by sex, age, and district of residence from the Barcelona population. Moreover, the prevalence of smokers in the sample (28.6% of men and 18.2% of women) was similar to that derived from the 2006 Health Interview Survey of Barcelona (27.3% of men and 20.6% of women) [43]. The participation rate was almost complete because the study design allowed replacement of non-respondents by subjects in the same strata of sex, age, and district of residence.

Conclusion

Cotinine concentration differed by sex and increased up to consumption of 20 cigarettes per day and then flattened at higher levels of smoking. Further investigation may help to better understand the relationship between number of cigarettes smoked, age, sex, weight, subjects' levels nicotine or cotinine concentrations, and the degree of nicotine dependence that may have implications in smoking cessation.

References

  1. 1.

    Benowitz NL: Pharmacology of nicotine: addiction and therapeutics. Ann Rev Pharmacol Toxicol. 1996, 36: 597-613. 10.1146/annurev.pa.36.040196.003121.

    CAS  Article  Google Scholar 

  2. 2.

    Benowitz NL: Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev. 1996, 18: 188-204.

    CAS  Article  PubMed  Google Scholar 

  3. 3.

    Al-Delaimy WK: Hair as a biomarker for exposure to tobacco smoke. Tob Control. 2002, 11: 176-182. 10.1136/tc.11.3.176.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  4. 4.

    Jaakkola MS, Jaakkola JJ: Assessment of exposure to environmental tobacco smoke. Eur Respir J. 1997, 10: 2384-2397. 10.1183/09031936.97.10102384.

    CAS  Article  PubMed  Google Scholar 

  5. 5.

    Jarvis MJ, Russell MA, Benowitz NL, Feyerabend C: Elimination of cotinine from body fluids: implications for noninvasive measurement of tobacco smoke exposure. Am J Public Health. 1988, 78: 696-698. 10.2105/AJPH.78.6.696.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  6. 6.

    Campuzano JC, Hernandez-Avila M, Jaakkola MS, Lazcano Ponce E, Kuri Morales P, Bautista P, Benowitz NL, Ceraso M, Blackford A, Samet JM: Determinants of salivary cotinine levels among current smokers in Mexico. Nicotine Tob Res. 2004, 6: 997-1008. 10.1080/14622200412331324956.

    CAS  Article  PubMed  Google Scholar 

  7. 7.

    Figueiredo VC, Szklo M, Szklo AS, Benowitz N, Lozana JA, Casado L, Masson E, Samet J: Determinants of salivary cotinine level: a population-based study in Brazil. Rev Saude Publica. 2007, 41: 954-962.

    Article  PubMed  Google Scholar 

  8. 8.

    Jaakkola MS, Ma J, Yang G, Chin MF, Benowitz NL, Ceraso M, Samet JM: Determinants of salivary cotinine concentrations in Chinese male smokers. Prev Med. 2003, 36: 282-290. 10.1016/S0091-7435(02)00037-3.

    CAS  Article  PubMed  Google Scholar 

  9. 9.

    Blackford AL, Yang G, Hernandez-Avila M, Przewozniak K, Zatonski W, Figueiredo V, vila-Tang E, Ma J, Benowitz NL, Samet JM: Cotinine concentration in smokers from different countries: relationship with amount smoked and cigarette type. Cancer Epidemiol Biomarkers Prev. 2006, 15: 1799-1804. 10.1158/1055-9965.EPI-06-0427.

    CAS  Article  PubMed  Google Scholar 

  10. 10.

    Lopez AD, Collishaw NE, Piha T: A descriptive model of the cigarette epidemic in developed countries. Tob Control. 1994, 3: 242-247. 10.1136/tc.3.3.242.

    Article  PubMed Central  Google Scholar 

  11. 11.

    Fernandez E, Schiaffino A, Borras JM, Shafey O, Villalbi JR, La Vecchia C: Prevalence of cigarette smoking by birth cohort among males and females in Spain, 1910-1990. Eur J Cancer Prev. 2003, 12: 57-62. 10.1097/00008469-200302000-00009.

    CAS  Article  PubMed  Google Scholar 

  12. 12.

    Ministerio de Sanidad y Consumo: Encuesta Nacional de Salud 2006. 2008, Madrid, Ministerio de Sanidad y Consumo, [http://www.msc.es/estadEstudios/estadisticas/encuestaNacional/encuestaNac2006/EstilosVidaPorcentaje.pdf]

    Google Scholar 

  13. 13.

    Fernandez E, Schiaffino A, Garcia M, Borras JM: Widening social inequalities in smoking cessation in Spain, 1987-1997. J Epidemiol Community Health. 2001, 55: 729-730. 10.1136/jech.55.10.729.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  14. 14.

    Schiaffino A, Fernandez E, Borrell C, Salto E, Garcia M, Borras JM: Gender and educational differences in smoking initiation rates in Spain from 1948 to 1992. Eur J Public Health. 2003, 13: 56-60. 10.1093/eurpub/13.1.56.

    Article  PubMed  Google Scholar 

  15. 15.

    Fernandez E: Spain: going smoke free. Tob Control. 2006, 15: 79-80.

    PubMed  Google Scholar 

  16. 16.

    Jacob P, Wilson M, Benowitz NL: Improved gas chromatographic method for the determination of nicotine and cotinine in biologic fluids. J Chromatogr. 1981, 222: 61-70. 10.1016/S0378-4347(00)81033-6.

    CAS  Article  PubMed  Google Scholar 

  17. 17.

    Pascual JA, Diaz D, Segura J, Garcia-Algar O, Vall O, Zuccaro P, Pacifici R, Pichini S: A simple and reliable method for the determination of nicotine and cotinine in teeth by gas chromatography/mass spectrometry. Rapid Commun Mass Spectrom. 2003, 17: 2853-2855. 10.1002/rcm.1279.

    Article  PubMed  Google Scholar 

  18. 18.

    Swan GE, Habina K, Means B, Jobe JB, Esposito JL: Saliva cotinine and recent smoking--evidence for a nonlinear relationship. Public Health Rep. 1993, 108: 779-783.

    CAS  PubMed  PubMed Central  Google Scholar 

  19. 19.

    Kleinbaum DG, Kupper LL, Muller KE: Applied regression analysis and other multivariable methods. 1988, Belmont, CA: Duxbury Press

    Google Scholar 

  20. 20.

    Fidler JA, Jarvis MJ, Mindell J, West R: Nicotine intake in cigarette smokers in England: distribution and demographic correlates. Cancer Epidemiol Biomarkers Prev. 2008, 17: 3331-3336. 10.1158/1055-9965.EPI-08-0296.

    CAS  Article  PubMed  Google Scholar 

  21. 21.

    Joseph AM, Hecht SS, Murphy SE, Carmella SG, Le CT, Zhang Y, Han S, Hatsukami DK: Relationships between cigarette consumption and biomarkers of tobacco toxin exposure. Cancer Epidemiol Biomarkers Prev. 2005, 14: 2963-2968. 10.1158/1055-9965.EPI-04-0768.

    CAS  Article  PubMed  Google Scholar 

  22. 22.

    Abrams DB, Follick MJ, Biener L, Carey KB, Hitti J: Saliva cotinine as a measure of smoking status in field settings. Am J Public Health. 1987, 77: 846-848. 10.2105/AJPH.77.7.846.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  23. 23.

    Etter JF, Perneger TV: Measurement of self reported active exposure to cigarette smoke. J Epidemiol Community Health. 2001, 55: 674-680. 10.1136/jech.55.9.674.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  24. 24.

    Caraballo RS, Giovino GA, Pechacek TF, Mowery PD, Richter PA, Strauss WJ, Sharp DJ, Eriksen MP, Pirkle JL, Maurer KR: Racial and ethnic differences in serum cotinine levels of cigarette smokers: Third National Health and Nutrition Examination Survey, 1988-1991. JAMA. 1998, 280: 135-139. 10.1001/jama.280.2.135.

    CAS  Article  PubMed  Google Scholar 

  25. 25.

    Rubinstein ML, Thompson PJ, Benowitz NL, Shiffman S, Moscicki AB: Cotinine levels in relation to smoking behavior and addiction in young adolescent smokers. Nicotine Tob Res. 2007, 9: 129-135. 10.1080/14622200601078517.

    CAS  Article  PubMed  Google Scholar 

  26. 26.

    Gan WQ, Cohen SB-Z, Paul Man SF, Sin DD: Sex-related differences in serum cotinine concentrations in daily cigarette smokers. Nicotine Tob Res. 2008, 10: 1293-1300. 10.1080/14622200802239132.

    CAS  Article  PubMed  Google Scholar 

  27. 27.

    Fidler JA, Jarvis MJ, Mindell J, West R: Nicotine intake in cigarette smokers in England: distribution and demographic correlates. Cancer Epidemiol Biomarkers Prev. 2008, 17: 3331-3336. 10.1158/1055-9965.EPI-08-0296.

    CAS  Article  PubMed  Google Scholar 

  28. 28.

    Olivieri M, Poli A, Zuccaro P, Ferrari M, Lampronti G, de Marco R, Lo Cascio V, Pacifici R: Tobacco smoke exposure and serum cotinine in a random sample of adults living in Verona, Italy. Arch Environ Health. 2002, 57: 355-359.

    CAS  Article  PubMed  Google Scholar 

  29. 29.

    Lubin JH, Caporaso N, Hatsukami DK, Joseph AM, Hecht SS: The association of a tobacco-specific biomarker and cigarette consumption and its dependence on host characteristics. Cancer Epidemiol Biomarkers Prev. 2007, 16: 1852-1857. 10.1158/1055-9965.EPI-07-0018.

    CAS  Article  PubMed  Google Scholar 

  30. 30.

    Henningfield JE, Benowitz NL: Pharmacology of nicotine addiction. Tobacco and public health: science and policy. Edited by: Boyle P, Gray N, Henningfield J, Seffrin J, Zatonski W. 2004, Oxford: Oxford University Press, 129-147.

    Google Scholar 

  31. 31.

    Le Houezec J: Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review. Int J Tuberc Lung Dis. 2003, 7: 811-819.

    CAS  PubMed  Google Scholar 

  32. 32.

    Vineis P, Esteve J, Hartge P, Hoover R, Silverman DT, Terracini B: Effects of timing and type of tobacco in cigarette-induced bladder cancer. Cancer Res. 1988, 48: 3849-3852.

    CAS  PubMed  Google Scholar 

  33. 33.

    Bartsch H, Caporaso N, Coda M, Kadlubar F, Malaveille C, Skipper P, Talaska G, Tannenbaum SR, Vineis P: Carcinogen hemoglobin adducts, urinary mutagenicity, and metabolic phenotype in active and passive cigarette smokers. J Natl Cancer Inst. 1990, 82: 1826-1831. 10.1093/jnci/82.23.1826.

    CAS  Article  PubMed  Google Scholar 

  34. 34.

    Kuenemann-Migeot C, Callais F, Momas I, Festy B: Urinary promutagens of smokers: comparison of concentration methods and relation to cigarette consumption. Mutat Res. 1996, 368: 141-147. 10.1016/0165-1218(96)00004-3.

    CAS  Article  PubMed  Google Scholar 

  35. 35.

    Malaveille C, Vineis P, Esteve J, Ohshima H, Brun G, Hautefeuille A, Gallet P, Ronco G, Terracini B, Bartsch H: Levels of mutagens in the urine of smokers of black and blond tobacco correlate with their risk of bladder cancer. Carcinogenesis. 1989, 10: 577-586. 10.1093/carcin/10.3.577.

    CAS  Article  PubMed  Google Scholar 

  36. 36.

    Benowitz NL, Jacob P, Kozlowski LT, Yu L: Influence of smoking fewer cigarettes on exposure to tar, nicotine, and carbon monoxide. N Engl J Med. 1986, 315: 1310-1313.

    CAS  Article  PubMed  Google Scholar 

  37. 37.

    Etter JF, Vu DT, Perneger TV: Saliva cotinine levels in smokers and nonsmokers. Am J Epidemiol. 2000, 151: 251-258.

    CAS  Article  PubMed  Google Scholar 

  38. 38.

    Fidler JA, Jarvis MJ, Mindell J, West R: Nicotine intake in cigarette smokers in England: distribution and demographic correlates. Cancer Epidemiol Biomarkers Prev. 2008, 17: 3331-3336. 10.1158/1055-9965.EPI-08-0296.

    CAS  Article  PubMed  Google Scholar 

  39. 39.

    O'Connor RJ, Giovino GA, Kozlowski LT, Shiffman S, Hyland A, Bernert JT, Caraballo RS, Cummings KM: Changes in Nicotine Intake and Cigarette Use Over Time in Two Nationally Representative Cross-Sectional Samples of Smokers. Am J Epidemiol. 2006, 164: 750-759. 10.1093/aje/kwj263.

    Article  PubMed  Google Scholar 

  40. 40.

    Patrick DL, Cheadle A, Thompson DC, Diehr P, Koepsell T, Kinne S: The validity of self-reported smoking: a review and meta-analysis. Am J Public Health. 1994, 84: 1086-1093. 10.2105/AJPH.84.7.1086.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  41. 41.

    Gorber SC, Schofield-Hurwitz S, Hardt J, Levasseur G, Tremblay M: The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status. Nicotine Tob Res. 2009, 11: 12-24. 10.1093/ntr/ntn010.

    Article  Google Scholar 

  42. 42.

    Klesges RC, Debon M, Ray JW: Are self-reports of smoking rate biased? Evidence from the Second National Health and Nutrition Examination Survey. J Clin Epidemiol. 1995, 48: 1225-1233. 10.1016/0895-4356(95)00020-5.

    CAS  Article  PubMed  Google Scholar 

  43. 43.

    Villalbi JR, Rodriguez-Sanz M, Villegas R, Borrell C: [Changes in the population smoking patterns: Barcelona, 1983-2006.]. Med Clin (Barc). 2009, 132: 414-419.

    Article  Google Scholar 

Pre-publication history

  1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2458/9/320/prepub

Download references

Acknowledgements

This project was funded by the Instituto de Salud Carlos III (grants FIS PI020261 & PI081436) and the Thematic Network of Cooperative Research on Cancer (grant RD06/0020/0089), Government of Spain, and the Ministry of Universities and Research (grant 2009SGR192), Government of Catalonia. We also thank Chupa Chups Spain for providing the Smint® candies.

* List of Determinants of COTinine (DCOT) Study investigators: Antoni Agudo, Carles Ariza, Josep M. Borràs, Esteve Fernández, Marcela Fu, Mireia Jané, Jose M. Martínez-Sánchez, Albert Moncada, Manel Nebot, José A. Pascual, Mercè Peris, Esteve Saltó, Jonathan M. Samet, Anna Schiaffino, and Jorge Twose.

Author information

Affiliations

  1. Tobacco Control & Research Unit, Institut Català d'Oncologia (ICO-IDIBELL), Av. Gran Via de L'Hospitalet 199-203, 08907, L'Hospitalet de Llobregat, (Barcelona), Spain

    Marcela Fu, Esteve Fernandez & Jose M Martínez-Sánchez

  2. Department of Clinical Sciences, School of Medicine, Campus de Bellvitge, Universitat de Barcelona. Pavelló de Govern, Feixa Llarga s/n, 08907, L'Hospitalet de Llobregat, (Barcelona), Spain

    Marcela Fu, Esteve Fernandez & Jose M Martínez-Sánchez

  3. Bioanalysis Research Group, Neuropsychopharmacology Programme, IMIM-Hospital del Mar. Parc de Recerca Biomèdica de Barcelona, Doctor Aiguader 88, Barcelona, Spain

    José A Pascual

  4. Department of Experimental and Health Sciences, Universitat Pompeu Fabra. Parc de Recerca Biomèdica de Barcelona, Doctor Aiguader 88, 08003, Barcelona, Spain

    José A Pascual

  5. Ajuntament de Terrassa, Crta. de Montcada 596, 08223, Terrassa, Spain

    Anna Schiaffino

  6. Nutrition, Environment & Cancer Unit, Institut Català d'Oncologia (ICO-IDIBELL), Av. Gran Via de L'Hospitalet 199-203, L'Hospitalet de Llobregat, (Barcelona), Spain

    Antoni Agudo

  7. Evaluation & Intervention Methods Unit, Agència de Salut Pública de Barcelona (ASPB), Pl. Lesseps 1, 08023, Barcelona, Spain

    Carles Ariza

  8. CIBER de Epidemiología y Salud Pública (CIBERESP), Parc de Recerca Biomèdica de Barcelona, Doctor Aiguader 88 1a Planta, 08003, Barcelona, Spain

    Carles Ariza

  9. Pla Director d'Oncologia, Av. Gran Via de L'Hospitalet 199-203, 08907, L'Hospitalet de Llobregat, (Barcelona), Spain

    Josep M Borràs

  10. Department of Preventive Medicine, USC Institute for Global Health, Keck School of Medicine USC, California, USA

    Jonathan M Samet

  11. Norris Comprehensive Cancer Center, 1441 Eastlake Avenue, Room 4436, MS 44, Los Angeles, CA, 90033, USA

    Jonathan M Samet

Authors
  1. Marcela Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Esteve Fernandez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jose M Martínez-Sánchez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. José A Pascual
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Anna Schiaffino
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Antoni Agudo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Carles Ariza
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Josep M Borràs
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jonathan M Samet
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

the DCOT Study investigators

Corresponding author

Correspondence to Esteve Fernandez.

Additional information

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

The DCOT investigators designed the study. JT, AS and MF co-ordinated participant recruitment, collected data and were responsible for data management. JAP was responsible for cotinine analyses. MF, JMMS, and EF performed statistical analyses. All authors participated in the interpretation of results. MF drafted the manuscript, and all authors contributed to the critical review and revision of the manuscript. All authors approved the final version of the manuscript. EF is the guarantor.

Electronic supplementary material

12889_2009_1723_MOESM1_ESM.pdf

Additional file 1: Supplemental material. Salivary cotinine concentration (ng/ml) in adult daily smokers in relation to the number of cigarettes smoked in the last 24 hours. Barcelona (Spain), 2004-2005, and Salivary cotinine concentration (ng/ml) in adult daily smokers in relation to the number of cigarettes smoked in the last 24 hours, in separate strata for men and women. Barcelona (Spain), 2004-2005. (PDF 184 KB)

Authors’ original submitted files for images

Below are the links to the authors’ original submitted files for images.

Authors’ original file for figure 1

Authors’ original file for figure 2

Rights and permissions

Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Fu, M., Fernandez, E., Martínez-Sánchez, J.M. et al. Salivary cotinine concentrations in daily smokers in Barcelona, Spain: a cross-sectional study. BMC Public Health 9, 320 (2009). https://doi.org/10.1186/1471-2458-9-320

Download citation

Keywords

  • Nicotine
  • Cotinine
  • Daily Smoker
  • Tobacco Exposure
  • Urinary Cotinine

BMC Public Health

ISSN: 1471-2458

Contact us